LON:PRM Proteome Sciences (PRM) Share Forecast, Price & News GBX 4.97 0.00 (0.00%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range 4.64▼ 5.4050-Day Range 3.36▼ 5.3552-Week Range 3.15▼ 5.45Volume170,202 shsAverage Volume299,113 shsMarket Capitalization£14.69 millionP/E Ratio418.00Dividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsInsider TradesHeadlinesProfileChartCompetitorsInsider TradesHeadlines About Proteome Sciences (LON:PRM) StockProteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. It also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers. In addition, the company offers bioinformatics tools, including Proteome Discoverer for peptide sequence and TMT quantitation; SQuaT,CalDIT, and DIANA for normalized quantitative values and functional annotation at peptide and protein level; FeaST for visualization of data quality, class identifier model, and biomarker candidate lists; and FAT for identification of biological processes and cellular components showing variance. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.Read More Receive PRM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Proteome Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address PRM Stock News HeadlinesMay 17, 2023 | marketwatch.comProteome Sciences Says It Is Well-Positioned for 2023 GrowthMay 12, 2023 | lse.co.ukProteome Sciences expanding to US with San Diego facilityJune 3, 2023 | Legacy Research (Affiliate) (Ad)“Amazon Loophole” could hand you $28,544 in “royalty” payoutsThanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.May 10, 2023 | americanbankingnews.comProteome Sciences (LON:PRM) Share Price Passes Above Fifty Day Moving Average of $3.91April 29, 2023 | fool.co.ukProteome SciencesApril 23, 2023 | americanbankingnews.comProteome Sciences (LON:PRM) Stock Passes Above 50 Day Moving Average of $3.91April 14, 2023 | americanbankingnews.comInsider Buying: Proteome Sciences plc (LON:PRM) Insider Acquires 100,000 Shares of StockApril 6, 2023 | americanbankingnews.comProteome Sciences plc (LON:PRM) Insider Acquires £400,000 in StockJune 3, 2023 | Legacy Research (Affiliate) (Ad)“Amazon Loophole” could hand you $28,544 in “royalty” payoutsThanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.March 8, 2023 | finance.yahoo.comDoes Proteome Sciences (LON:PRM) Deserve A Spot On Your Watchlist?January 25, 2023 | finanznachrichten.deAdvanced Proteome Therapeutics Corp.: Advanced Proteome Therapeutics Announces Its Proposed Plan of ArrangementAugust 30, 2022 | finance.yahoo.comHere's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of InvestorsAugust 5, 2022 | lse.co.ukProteome reaches milestone in launch of proteomics serviceMay 17, 2022 | lse.co.ukProteome Sciences maintains strong order bookDecember 14, 2021 | apnews.comBiognosys Expands Co-Marketing Agreement with Global Life Science Leader to Advance ProteomicsDecember 7, 2021 | finance.yahoo.comHere's Why I Think Proteome Sciences (LON:PRM) Might Deserve Your Attention TodayNovember 15, 2021 | finance.yahoo.comThermo Fisher Scientific Advances Proteomics Through Select Collaborations and New Analytical Instrument SolutionsSeptember 6, 2021 | finance.yahoo.comA Look At The Fair Value Of Proteome Sciences plc (LON:PRM)June 8, 2021 | finance.yahoo.comI Ran A Stock Scan For Earnings Growth And Proteome Sciences (LON:PRM) Passed With EaseMay 13, 2021 | markets.businessinsider.comProteome Sciences : Price Monitoring ExtensionMay 11, 2021 | markets.businessinsider.comProteome Sciences : AGM StatementMay 11, 2021 | markets.businessinsider.comProteome Sciences : Result of AGMApril 5, 2021 | finance.yahoo.comProteome Sciences plc's (LON:PRM) Price Is Out Of Tune With EarningsMarch 28, 2021 | lse.co.ukProteome profit to be higher than expected thanks to royalties boostMarch 25, 2021 | barrons.comProteome Sciences PLCFebruary 12, 2021 | marketwatch.comBiomarker Research Services Market will Likely see Expanding of Marketable Business Segment | Noble Life Sciences Inc, ReproCELL USA IncJanuary 3, 2021 | markets.businessinsider.comProteome Sciences PLCShs Stock , PMSNFSee More Headlines PRM Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRM Company Calendar Last Earnings8/10/2020Today6/03/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Medical Laboratories & Research Sub-IndustryN/A SectorMedical Current SymbolLON:PRM CUSIPN/A CIKN/A Webwww.proteomics.com Phone+44-20-70432116FaxN/AEmployees24Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio418.00 Forward P/E RatioN/A P/E GrowthN/ANet Income£1.32 million Net Margins17.03% Pretax MarginN/A Return on EquityN/A Return on Assets9.61% Debt Debt-to-Equity RatioN/A Current Ratio0.55 Quick Ratio0.37 Sales & Book Value Annual Sales£7.78 million Price / Sales1.89 Cash FlowGBX 1.33 per share Price / Cash Flow3.73 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares295,180,000Free FloatN/AMarket Cap£14.69 million OptionableNot Optionable Beta0.01 Key ExecutivesDr. Mariola Sohngen (Age 61)CEO & Exec. Director Comp: $258kDr. Ian H. PikeChief Scientific Officer & Exec. DirectorMr. Richard Paul Dennis (Age 63)Chief Commercial Officer & Exec. Director Comp: $225kMr. Abdelghani Omari (Age 45)CFO & Director Mr. Glenn BarneyVP of Sales & MarketingVictoria BirseCompany Sec.More ExecutivesKey CompetitorsANGLELON:AGLAbingdon HealthLON:ABDXRealm TherapeuticsLON:RLMKanabo GroupLON:KNBGENinCodeLON:GENIView All CompetitorsInsidersMartin DiggleBought 100,000 shares on 4/13/2023Total: £400,000.00 ($4.00/share)Martin DiggleBought 100,000 shares on 4/5/2023Total: £40 M ($400.00/share)View All Insider Transactions PRM Stock - Frequently Asked Questions How have PRM shares performed in 2023? Proteome Sciences' stock was trading at GBX 3.50 on January 1st, 2023. Since then, PRM stock has increased by 42.1% and is now trading at GBX 4.98. View the best growth stocks for 2023 here. How were Proteome Sciences' earnings last quarter? Proteome Sciences plc (LON:PRM) released its quarterly earnings results on Monday, August, 10th. The company reported ($0.17) earnings per share (EPS) for the quarter. What other stocks do shareholders of Proteome Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Proteome Sciences investors own include ValiRx (VAL), boohoo group (BOO), Mondi (MNDI), Petrofac (PFC), Lloyds Banking Group (LLOY), Falanx Group (FLX), Quanterix (QTRX), Centrica (CNA), CyanConnode (CYAN) and Eckoh (ECK). What is Proteome Sciences' stock symbol? Proteome Sciences trades on the London Stock Exchange (LON) under the ticker symbol "PRM." How do I buy shares of Proteome Sciences? Shares of PRM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Proteome Sciences' stock price today? One share of PRM stock can currently be purchased for approximately GBX 4.98. How much money does Proteome Sciences make? Proteome Sciences (LON:PRM) has a market capitalization of £14.69 million and generates £7.78 million in revenue each year. How can I contact Proteome Sciences? Proteome Sciences' mailing address is Hamilton House, Mabledon Place, LONDON, WC1H 9BB, United Kingdom. The official website for the company is www.proteomics.com. The company can be reached via phone at +44-20-70432116. This page (LON:PRM) was last updated on 6/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Proteome Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.